Revitalist Increases Clinic Count to Nine With Closing of Florida Clinic Acquisition
Ryan Allway January 12th, 2022 Psychedelics, Top News REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce that it has executed an asset purchase agreement (“Agreement”) dated January 11, 2022, to acquire a Ketamine clinic located in Jacksonville, Florida... Read more
Health Canada’s SAP Amendments: A Game-Changer For Psychedelic Medicine In Canada?

On January 5, 2022, Health Canada amendments to its Special Access Program has expanded access to psychedelic drug therapies. We explore the implications.

Read more
Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development

Field Trip announces receiving its USPTO patent for FT-104, including composition of matter.

Read more
Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial

Awakn announces strong results from its Phase II a/b clinical trial of a ketamine-assisted therapy for Alcohol Use Disorder (AUD).

Read more
Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Wesana announces a pre-IND meeting with the FDA for SANA-013 in March, it’s lead drug candidate for Traumatic Brain Injury.

Read more
Organigram Reports First Quarter Fiscal 2022 Results $30.4 million net revenue represents a record for the Company as it solidifies #4 market share position nationally among Canadian LPs HIGHLIGHTS 23% growth in gross revenue to $44.3 million from Q4 Fiscal 2021 and 75% from the same prior-year period Achieved... Read more
Leafly and Merida Merger Corp. I Announce $30M Convertible Note Financing New investment fully funds Leafly’s current multi-year business plan upon closing of business combination Special meeting of Merida stockholders will be moved to a later date to vote on proposed business combination SEATTLE–(BUSINESS WIRE)– Leafly Holdings Inc. (“Leafly”),... Read more
Biomica Announces Clearance for First-in-Human Phase I Study of BMC-128 in Combination with Bristol Myers Squibb’s Anti-PD-1 Opdivo®
Ryan Allway January 11th, 2022 Clearance for Proof-of-Concept Phase I human trial in oncology received from Israeli Ministry of Health REHOVOT, Israel, Jan. 11, 2022 /PRNewswire/ — Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced that the Israeli... Read more
Ryan Allway January 11th, 2022 Agreement establishes YourWay as the exclusive Old Pal cannabis licensee in ArizonaA best-selling, national brand bolsters YourWay’s partner portfolio,positioning YourWay as a leading consumer-centric cannabis company in Arizona VANCOUVER, BC – YourWay Cannabis Brands Inc. (CSE: YOUR) (OTC: YOURF) (FSE: HOB) (the “Company” or “YourWay“) today announced it has... Read more
Michigan closed out 2021 with another record-breaking month of adult-use marijuana sales in December, state officials say. The state saw more than $135 million in recreational cannabis purchases and about $33 million in medical marijuana sales last month. Andrew Brisbo, executive director of the Michigan Marijuana Regulatory Agency (MRA),... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )